Publication | Open Access
Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease
26
Citations
0
References
2003
Year
NeurogenomicsNeurochemical BiomarkersSocial SciencesOxidative StressAlzheimer's DiseaseDegenerative PathologyNeurologyAging-associated DiseaseNeurochemistryMolecular NeuroscienceEyal NeriaMedicineNeuropharmacologyNeuroprotectionNeurodegenerationPharmacologyMelatoninNeurodegenerative DiseasesNeurophysiologyDementiaJ. NeurochemNeuroscienceMolecular NeurobiologyTransgenic ModelAmyloid PathologyMindset Biopharmaceuticals
The authors wish to make a correction to the above article that was published in J. Neurochem. 85, pp. 11011108. Authors Daniel G. Chain and Eyal Neria were omitted and this has been amended above. The authors also wish to acknowledge that this work has been supported by a NIA grant AG 16783 and by Mindset BioPharmaceuticals (USA) Inc.